Maureen Beresini
Senior Scientist, Technology
"We are building a significant portfolio of projects at various stages to fuel the small molecule pipeline."
- 21
years at Genentech - 4
publications (2010-12) - 5
awards & honors
I joined Genentech in 1992 because of its reputation for outstanding science. What impressed me most when I arrived was the strongly collaborative relationships that quickly developed among my colleagues. I feel fortunate that my position has allowed me to connect my past experiences in protein chemistry as a graduate student, cell biology as a postdoctoral fellow, and assay development gained in industry.
The past 20 years have continued to provide me with opportunities to learn and grow scientifically while allowing me to contribute to the discovery of small molecule therapeutics. It has been extremely rewarding to be a part of the growth and development of the small molecule organization from one that makes potent, selective molecules to one that makes drugs that benefit patients.
Featured Publication
Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready plates.
J Biomol Screen. 2012 Feb;17(2):225-36. Epub 2011 Sep 22.
Liu Y, Beresini MH, Johnson A, Mintzer R, Shah K, Clark K, Schmidt S, Lewis C, Liimatta M, Elliott LO, Gustafson A, Heise CE.
View Abstract on PubMed
